6:20 PM
 | 
Oct 23, 2012
 |  BC Extra  |  Politics & Policy

FDA to discuss teratogenic risk management

FDA's Drug Safety and Risk Management Advisory Committee will meet on Dec. 12-13 to discuss the risk...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >